Lionel Low

611 total citations
8 papers, 489 citations indexed

About

Lionel Low is a scholar working on Immunology, Oncology and Epidemiology. According to data from OpenAlex, Lionel Low has authored 8 papers receiving a total of 489 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Immunology, 4 papers in Oncology and 2 papers in Epidemiology. Recurrent topics in Lionel Low's work include CAR-T cell therapy research (4 papers), Immunotherapy and Immune Responses (3 papers) and Immune Cell Function and Interaction (3 papers). Lionel Low is often cited by papers focused on CAR-T cell therapy research (4 papers), Immunotherapy and Immune Responses (3 papers) and Immune Cell Function and Interaction (3 papers). Lionel Low collaborates with scholars based in Singapore, United States and United Kingdom. Lionel Low's co-authors include Bart N. Lambrecht, Magali Bébien, Leonie S. van Rijt, John Goulding, Tracy Hussell, Arnaud M. Didierlaurent, Seema R. Patel, Robert J. Snelgrove, Toby Lawrence and Jean‐Claude Sirard and has published in prestigious journals such as Nature Communications, The Journal of Experimental Medicine and ACS Nano.

In The Last Decade

Lionel Low

8 papers receiving 484 citations

Peers

Lionel Low
Josephine Nguyen United States
Weimin Nie China
Cristina Mansilla Spain
Hadar Cohen Israel
Lynnelle A. Pittet United States
Kiyomitsu Katsumata Japan
Anya Hammann‐Haenni Germany
Bin Ni United States
Wei-Lun Huang Taiwan
Wassana Wijagkanalan Thailand
Josephine Nguyen United States
Lionel Low
Citations per year, relative to Lionel Low Lionel Low (= 1×) peers Josephine Nguyen

Countries citing papers authored by Lionel Low

Since Specialization
Citations

This map shows the geographic impact of Lionel Low's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lionel Low with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lionel Low more than expected).

Fields of papers citing papers by Lionel Low

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lionel Low. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lionel Low. The network helps show where Lionel Low may publish in the future.

Co-authorship network of co-authors of Lionel Low

This figure shows the co-authorship network connecting the top 25 collaborators of Lionel Low. A scholar is included among the top collaborators of Lionel Low based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lionel Low. Lionel Low is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Teo, Pei Y., David H. Quach, Richard Ong, et al.. (2024). Overexpression of an Engineered SERPINB9 Enhances Allogeneic T-cell Persistence and Efficacy. Cancer Immunology Research. 12(8). 1108–1122. 1 indexed citations
2.
Yeo, Siok Ping, Lindsay Kua, Chek Meng Poh, et al.. (2024). B7-H3–Targeting Chimeric Antigen Receptors Epstein-Barr Virus–specific T Cells Provides a Tumor Agnostic Off-The-Shelf Therapy Against B7-H3–positive Solid Tumors. Cancer Research Communications. 4(6). 1410–1429. 3 indexed citations
3.
Ng, Chee H., Cheah C. Seh, Richard Ong, et al.. (2024). Novel OX40 and 4-1BB derived spacers enhance CD30 CAR activity and safety in CD30 positive lymphoma models. Molecular Therapy. 32(10). 3504–3521. 3 indexed citations
4.
Low, Lionel, et al.. (2019). Targeting mutant p53-expressing tumours with a T cell receptor-like antibody specific for a wild-type antigen. Nature Communications. 10(1). 5382–5382. 40 indexed citations
5.
6.
Low, Lionel, Adam J. Gehring, Zi Zong Ho, et al.. (2012). Binding of TCR Multimers and a TCR-Like Antibody with Distinct Fine-Specificities Is Dependent on the Surface Density of HLA Complexes. PLoS ONE. 7(12). e51397–e51397. 2 indexed citations
7.
Sastry, Konduru S., Kaval Kaur, Adam J. Gehring, et al.. (2010). Targeting Hepatitis B Virus-Infected Cells with a T-Cell Receptor-Like Antibody. Journal of Virology. 85(5). 1935–1942. 49 indexed citations
8.
Didierlaurent, Arnaud M., John Goulding, Seema R. Patel, et al.. (2008). Sustained desensitization to bacterial Toll-like receptor ligands after resolutionof respiratory influenza infection. The Journal of Experimental Medicine. 205(2). 323–329. 307 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Josephine Nguyen Breakdown of academic impact, for papers by Weimin Nie Breakdown of academic impact, for papers by Cristina Mansilla Breakdown of academic impact, for papers by Hadar Cohen Breakdown of academic impact, for papers by Lynnelle A. Pittet Breakdown of academic impact, for papers by Kiyomitsu Katsumata Breakdown of academic impact, for papers by Anya Hammann‐Haenni Breakdown of academic impact, for papers by Bin Ni Breakdown of academic impact, for papers by Wei-Lun Huang Breakdown of academic impact, for papers by Wassana Wijagkanalan
Rankless by CCL
2026